The tumor progression, including resistance of apoptosis, angiogenesis, and proliferation, is strongly influenced by higher infiltration of M2‐TAM (CD163 and 204) and upregulation of STAT3, NF‐κB pathways. This evidence concerns the gene NFKB1 and neoplasm.